Intravenous (IV) Therapy and Vein Access Market will witness significant growth rates owing to proliferating traffic accidents and trauma cases. It is a therapy of offering fluids through a vein. Shifting trend towards enhanced techniques including needleless adding fluids, blood and medication drugs will positively influence the product demand.
The global Intravenous Therapy and Vein Access Market is projected to reach US$ 37 billion by 2028, growing at a CAGR of 5.1% from 2023 to 2028.
Growing prevalence across chronic diseases along with increasing number of surgical procedures will drive the intravenous (IV) therapy and vein access market. Daily multiple number of healthcare operators handle fluids, blood and drugs. Regardless of care taken during handling, peril of exposure still remains high. Risk of reactions and consistent requirement of skilled medical personnel may restrict the business growth.
Global Intravenous (IV) Therapy and Vein Access Market is segregated on the basis of product as, Implantable ports, Intravenous Catheter, Infusion Pumps, and Hypodermic Needles. Based on application, the global Intravenous (IV) Therapy and Vein Access market is segmented as Nutrition & Buffer Solution, Blood-based Products, Medication Administration, Volume Expanders, Other Applications. The report also bifurcates global Intravenous (IV) Therapy and Vein Access market based on End-User as Hospitals, Clinics, Ambulatory Surgical Centres, and Other End-Users.
Global Intravenous (IV) Therapy and Vein Access market report provides geographic analysis covering regions such as North America, Europe, Asia Pacific, and Rest of World. The Intravenous (IV) Therapy and Vein Access market for each region is further segmented for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.
Competitive Rivalry
Fresenius Se & co. KGAA, Insulet Corporation, Pfizer Inc., Angiodynamics, Inc., Smith & Nephew Plc., Medtronic Inc., Teleflex Medical Inc., Terumo Medical Corporation, B.Braun Melsungen Ag, Becton, Dickinson and Company are among the major players in the global Intravenous (IV) Therapy and Vein Access market share. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Intravenous (IV) Therapy and Vein Access Market has been segmented as below:
Intravenous (IV) Therapy and Vein Access Market, By Product
Intravenous (IV) Therapy and Vein Access Market, By Application
Intravenous (IV) Therapy and Vein Access Market, By End-User
Intravenous (IV) Therapy and Vein Access Market, By Region
The report covers:
Report scope:
Global Intravenous (IV) Therapy and Vein Access market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Intravenous (IV) Therapy and Vein Access market share. Major industry players with significant revenue share include Fresenius Se & co. KGAA, Insulet Corporation, Pfizer Inc., Angiodynamics, Inc., Smith & Nephew Plc., Medtronic Inc., Teleflex Medical Inc., Terumo Medical Corporation, B.Braun Melsungen Ag, Becton, and Dickinson and Company.
Reasons to Buy this Report:
Customization:
Customized report as per the requirement can be offered with appropriate recommendations
Below are our New Reports :-
Tick-borne Encephalitis Vaccine market
Single Blood Drop Analysis Market
pharmaceutical excipients market
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.2.1. Increasing advantages of IV therapy and vein access devices
4.2.2. Growing number of traffic accidents & trauma cases
4.2.3. Increasing penetration across chronic diseases
4.2.4. Increasing Geriatric Population and Rising Incidence of Various Diseases
4.3. Restraints
4.3.1. Lack of skilled professionals and risk of allergic reactions
4.4. Opportunities
4.4.1. Improving Healthcare Infrastructure
4.4.2. Rising Demand for Diagnosis
4.5. Challenges
4.5.1. Stringent Healthcare Regulations
5. Intravenous (IV) Therapy and Vein Access Market, By Product
5.1. Key Points
5.2. Implantable ports
5.2.1. Single Lumen
5.2.2. Double Lumen
5.3. Intravenous Catheter
5.3.1. Peripherally Inserted
5.3.2. Peripheral
5.3.3. Central
5.4. Infusion Pumps
5.5. Hypodermic Needles,
5.6. Others
6. Intravenous (IV) Therapy and Vein Access Market, By Application
6.1. Key Points
6.2. Nutrition & Buffer Solution
6.3. Blood-based Products
6.4. Medication Administration
6.5. Volume Expanders
6.6. Other Applications
7. Intravenous (IV) Therapy and Vein Access Market, By End-Use
7.1. Key Points
7.2. Hospitals
7.3. Clinics
7.4. Ambulatory Surgical Centres
7.5. Other End-Users
8. Competitive Landscape
8.1. Introduction
8.2. Recent Developments
8.2.1. Mergers & Acquisitions
8.2.2. New Product Developments
8.2.3. Portfolio/Production Capacity Expansions
8.2.4. Joint Ventures, Collaborations, Partnerships & Agreements
8.2.5. Others
9. Company Profile
9.1. Fresenius Se & co. KGAA
9.1.1. Company Overview
9.1.2. Product/Service Landscape
9.1.3. Financial Overview
9.1.4. Recent Developments
9.2. Insulet Corporation
9.2.1. Company Overview
9.2.2. Product/Service Landscape
9.2.3. Financial Overview
9.2.4. Recent Developments
9.3. Pfizer Inc.
9.3.1. Company Overview
9.3.2. Product/Service Landscape
9.3.3. Financial Overview
9.3.4. Recent Developments
9.4. Angiodynamics, Inc.
9.4.1. Company Overview
9.4.2. Product/Service Landscape
9.4.3. Financial Overview
9.4.4. Recent Developments
9.5. Smith & Nephew Plc.
9.5.1. Company Overview
9.5.2. Product/Service Landscape
9.5.3. Financial Overview
9.5.4. Recent Developments
9.6. Medtronic Inc.
9.6.1. Company Overview
9.6.2. Product/Service Landscape
9.6.3. Financial Overview
9.6.4. Recent Developments
9.7. Teleflex Medical Inc.
9.7.1. Company Overview
9.7.2. Product/Service Landscape
9.7.3. Financial Overview
9.7.4. Recent Developments
9.8. Terumo Medical Corporation
9.8.1. Company Overview
9.8.2. Product/Service Landscape
9.8.3. Financial Overview
9.8.4. Recent Developments
9.9. B.Braun Melsungen Ag
9.9.1. Company Overview
9.9.2. Product/Service Landscape
9.9.3. Financial Overview
9.9.4. Recent Developments
9.10. Becton, Dickinson and Company
9.10.1. Company Overview
9.10.2. Product/Service Landscape
9.10.3. Financial Overview
9.10.4. Recent Developments
The Intravenous (IV) Therapy and Vein Access Market has been segmented as below:
Intravenous (IV) Therapy and Vein Access Market, By Product
Intravenous (IV) Therapy and Vein Access Market, By Application
Intravenous (IV) Therapy and Vein Access Market, By End-User
Intravenous (IV) Therapy and Vein Access Market, By Region
